🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to look at how a type of drug called cannabinoids...
Status
Completed
Location
Eugene Applebaum College of Pharmacy and Health Sciences
Start Date
2014-11
Trial ID
NCT02069366
Treatments Being Tested
This is a Phase IIa study assessing the safety, tolerability and preliminar...
Status
Completed
Location
Alzheimer's Research and Treatment Center
Start Date
2019-05-16
Trial ID
NCT03867253
Treatments Being Tested
This is a Phase 1, 2-part double-blinded (with respect to NX-5948/placebo),...
Status
Completed
Location
Celerion
Start Date
2024-08-20
Trial ID
NCT06593457
Treatments Being Tested
This is a clinical trial that tested whether a 12-week exercise program usi...
Status
Completed
Location
Sun Yat-sen University Cancer Prevention Center
Start Date
2023-07-10
Trial ID
NCT07003607
Immediate post-suturing administration of either one of two dental anesthet...
Status
Completed
Location
The University of Texas Health Science Center at San Antonio
Start Date
2022-06-06
Trial ID
NCT06293807
Treatments Being Tested
A multi center, randomized study to evaluate the efficacy and safety of esz...
Status
Completed
Location
Sleep Disorders Center of Alabama
Start Date
2009-05
Trial ID
NCT00856973
Treatments Being Tested
The goal of this clinical trial is to learn if IMM0306 works to reduce the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07621939
To assess the efficacy and safety of AGY vs placebo when administered to in...
Status
Completed
Location
University of Alberta
Start Date
2019-10-29
Trial ID
NCT03707730
This study will assess the hemodynamic effect of RLX030 infusion in subject...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01543854
The primary objective for this study is to evaluate whether Rituximab as co...
Status
Enrolling By Invitation
Location
Uppsala University Hospital
Start Date
2022-05-01
Trial ID
NCT04323566
Treatments Being Tested